Latest Vestal Point Capital, LP Stock Portfolio
Vestal Point Capital, LP Performance:
2024 Q3: 4.58%YTD: -4.83%
Performance for 2024 Q3 is 4.58%, and YTD is -4.83%.
About Vestal Point Capital, LP and 13F Hedge Fund Stock Holdings
Vestal Point Capital, LP is a hedge fund based in NEW YORK, NY. On 10-Aug-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.3 Billions. In it's latest 13F Holdings report, Vestal Point Capital, LP reported an equity portfolio of $1.3 Billions as of 30 Sep, 2024.
The top stock holdings of Vestal Point Capital, LP are INSM, JAZZ, CYTK. The fund has invested 8.9% of it's portfolio in INSMED INC and 7.6% of portfolio in JAZZ PHARMACEUTICALS PLC.
The fund managers got completely rid off GLOBUS MEDICAL INC (GMED), BEIGENE LTD (BGNE) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in APPLIED THERAPEUTICS INC (APLT), ASCENDIS PHARMA A/S and RELMADA THERAPEUTICS INC (RLMD). Vestal Point Capital, LP opened new stock positions in AGIOS PHARMACEUTICALS INC (AGIO), BIOMARIN PHARMACEUTICAL INC (BMRN) and EDWARDS LIFESCIENCES CORP (EW). The fund showed a lot of confidence in some stocks as they added substantially to INARI MEDICAL INC (NARI), BLACK DIAMOND THERAPEUTICS INC (BDTX) and PRIME MEDICINE INC.
The top stock holdings of Vestal Point Capital, LP are INSM, JAZZ, CYTK. The fund has invested 8.9% of it's portfolio in INSMED INC and 7.6% of portfolio in JAZZ PHARMACEUTICALS PLC.
The fund managers got completely rid off GLOBUS MEDICAL INC (GMED), BEIGENE LTD (BGNE) and EXACT SCIENCES CORP (EXAS) stocks. They significantly reduced their stock positions in APPLIED THERAPEUTICS INC (APLT), ASCENDIS PHARMA A/S and RELMADA THERAPEUTICS INC (RLMD). Vestal Point Capital, LP opened new stock positions in AGIOS PHARMACEUTICALS INC (AGIO), BIOMARIN PHARMACEUTICAL INC (BMRN) and EDWARDS LIFESCIENCES CORP (EW). The fund showed a lot of confidence in some stocks as they added substantially to INARI MEDICAL INC (NARI), BLACK DIAMOND THERAPEUTICS INC (BDTX) and PRIME MEDICINE INC.
Vestal Point Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Vestal Point Capital, LP made a return of 4.58% in the last quarter. In trailing 12 months, it's portfolio return was 17.16%.
New Buys
| Ticker | $ Bought |
|---|---|
| agios pharmaceuticals inc | 33,766,800 |
| biomarin pharmaceutical inc | 28,116,000 |
| edwards lifesciences corp | 18,147,200 |
| gilead sciences inc | 16,768,000 |
| agilent technologies inc | 14,848,000 |
| gsk plc | 12,264,000 |
| bicara therapeutics inc | 10,824,800 |
| crinetics pharmaceuticals inc | 10,475,500 |
New stocks bought by Vestal Point Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| inari medical inc | 342 |
| black diamond therapeutics inc | 139 |
| prime medicine inc | 137 |
| insmed inc | 113 |
| structure therapeutics inc | 105 |
| day one biopharmaceuticals inc | 100 |
| kalvista pharmaceuticals inc | 73.91 |
| xenon pharmaceuticals inc | 57.14 |
Additions to existing portfolio by Vestal Point Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| applied therapeutics inc | -78.91 |
| ascendis pharma a/s | -66.67 |
| relmada therapeutics inc | -59.17 |
| ultragenyx pharmaceutical inc | -58.33 |
| bristol-myers squibb co | -50.00 |
| iteos therapeutics inc | -41.43 |
| jazz pharmaceuticals plc | -40.00 |
| soleno therapeutics inc | -40.00 |
Vestal Point Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| alx oncology holdings inc | -21,708,000 |
| fulcrum therapeutics inc | -7,192,000 |
| immunome inc | -12,100,000 |
| exact sciences corp | -39,081,200 |
| globus medical inc | -61,641,000 |
| denali therapeutics inc | -11,610,000 |
| praxis precision medicines inc | -18,198,400 |
| beigene ltd | -49,934,500 |
Vestal Point Capital, LP got rid off the above stocks
Sector Distribution
Vestal Point Capital, LP has about 82.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 82.3 |
| Others | 17.7 |
Market Cap. Distribution
Vestal Point Capital, LP has about 17% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 36.9 |
| SMALL-CAP | 26.7 |
| UNALLOCATED | 17.7 |
| LARGE-CAP | 17 |
| MICRO-CAP | 1.5 |
Stocks belong to which Index?
About 56.5% of the stocks held by Vestal Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 51 |
| Others | 43.5 |
| S&P 500 | 5.5 |
Vestal Point Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Vestal Point Capital, LP
Vestal Point Capital, LP has 67 stocks in it's portfolio. About 48.7% of the portfolio is in top 10 stocks. NARI proved to be the most loss making stock for the portfolio. RARE was the most profitable stock for Vestal Point Capital, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 1.13 | 100,000 | 14,848,000 | new | |||
| ACHL | achilles therapeutics plc | 0.12 | 1,500,000 | 1,530,000 | unchanged | 0.00 | ||
| ACLX | arcellx inc | 4.28 | 675,000 | 56,369,200 | unchanged | 0.00 | ||
| AGIO | agios pharmaceuticals inc | 2.56 | 760,000 | 33,766,800 | new | |||
| ALLO | allogene therapeutics inc | 0.32 | 1,500,000 | 4,200,000 | reduced | -31.82 | ||
| ALXO | alx oncology holdings inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLT | applied therapeutics inc | 0.74 | 1,145,000 | 9,732,500 | reduced | -78.91 | ||
| ARDX | ardelyx inc | 0.26 | 500,000 | 3,445,000 | new | |||
| ATRA | atara biotherapeutics inc | 0.08 | 124,677 | 1,013,620 | added | 11.32 | ||
| ATXS | astria therapeutics inc | 3.34 | 4,000,000 | 44,040,000 | added | 23.08 | ||
| AXSM | axsome therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDTX | black diamond therapeutics inc | 1.66 | 5,028,500 | 21,874,000 | added | 139 | ||
| BDX | becton dickinson & co | 0.55 | 30,000 | 7,233,000 | new | |||
| BGNE | beigene ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMRN | biomarin pharmaceutical inc | 2.13 | 400,000 | 28,116,000 | new | |||
| BMY | bristol-myers squibb co | 0.98 | 250,000 | 12,935,000 | reduced | -50.00 | ||
| BRKR | bruker corp | 0.66 | 125,000 | 8,632,500 | new | |||
| CMRX | chimerix inc | 0.10 | 1,400,000 | 1,302,000 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals inc | 0.79 | 205,000 | 10,475,500 | new | |||